Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Login and Edit is currently disabled

Rachel Ann Freedman, M.D.

Concepts (304)

Back to Profile
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Breast Neoplasms1272024211786.130 Why?
Chemotherapy, Adjuvant32202435522.240 Why?
Receptor, erbB-224202225992.140 Why?
Breast Neoplasms, Male720242131.760 Why?
SEER Program24202414441.630 Why?
Antineoplastic Agents, Hormonal10202115361.560 Why?
Mastectomy16202318611.310 Why?
Antineoplastic Combined Chemotherapy Protocols232024118721.290 Why?
Quinolines520227701.030 Why?
Neoplasm Staging322024112170.950 Why?
Survivors11202323810.920 Why?
Health Literacy220234660.890 Why?
Mastectomy, Segmental920249740.790 Why?
Mammography7202224310.770 Why?
Medical Oncology7202123410.770 Why?
Health Knowledge, Attitudes, Practice5201940540.770 Why?
Axilla520246220.770 Why?
Female13420243966600.720 Why?
Healthcare Disparities9202434140.710 Why?
Life Expectancy5202412480.700 Why?
Radiotherapy, Adjuvant7201617880.700 Why?
Aged8720241713190.690 Why?
Self-Help Groups120211940.670 Why?
Brain Neoplasms7202091080.620 Why?
Clinical Trials as Topic10202480480.610 Why?
Neoplasm Metastasis15202148920.590 Why?
Neoplasm Recurrence, Local13202494100.590 Why?
Neoplasms, Second Primary3202410610.550 Why?
Receptors, Estrogen13202422520.550 Why?
Aged, 80 and over412024595480.540 Why?
Humans14620247670400.530 Why?
Antineoplastic Agents112020136500.530 Why?
Receptors, Progesterone8202111590.520 Why?
Patient Selection5202142560.520 Why?
Age Factors182024184010.510 Why?
Carcinoma, Intraductal, Noninfiltrating520249340.500 Why?
Carcinoma, Ductal, Breast6201910970.490 Why?
Interdisciplinary Communication120219350.490 Why?
Patient Participation2202114440.490 Why?
Hormone Replacement Therapy120207560.470 Why?
Breast10202319720.460 Why?
Estrogen Replacement Therapy1202012090.440 Why?
Population Surveillance4201825940.410 Why?
Middle Aged6020242232330.410 Why?
Choice Behavior220168480.400 Why?
Epothilones12011420.380 Why?
Withholding Treatment120156190.370 Why?
Social Support1202121920.370 Why?
Paclitaxel5202217280.360 Why?
Geriatrics320203940.360 Why?
Neoplasms, Hormone-Dependent120134090.360 Why?
United States332024729710.350 Why?
Benzothiazoles120112440.350 Why?
Prognosis162023299630.340 Why?
Geriatric Assessment2202314220.330 Why?
Health Services Accessibility3201955190.320 Why?
Lymph Nodes2201734680.310 Why?
Carboplatin220227900.310 Why?
Neoplasms72022223500.310 Why?
Adult4520242233170.300 Why?
Combined Modality Therapy9202485350.300 Why?
Health Education1201510580.300 Why?
Protein Kinase Inhibitors3202456930.300 Why?
Aminopyridines220225780.290 Why?
Patient Preference120159470.280 Why?
Registries11202383510.280 Why?
Medical History Taking120117790.280 Why?
Kaplan-Meier Estimate9202465130.280 Why?
Tonsillar Neoplasms12007490.280 Why?
Referral and Consultation5202336180.280 Why?
Insurance, Health4201725190.270 Why?
Disease-Free Survival7202168440.270 Why?
Benzimidazoles220228620.270 Why?
Myelodysplastic Syndromes1201613990.270 Why?
Mammaplasty2201712680.260 Why?
Socioeconomic Factors4202078480.260 Why?
Paget's Disease, Mammary22015180.250 Why?
Mass Screening2202154560.250 Why?
Enoxaparin120083910.250 Why?
Genetic Testing1201835910.240 Why?
Hospitals2201638830.240 Why?
Postmenopause3202425180.240 Why?
Tamoxifen420249660.230 Why?
Insurance Coverage3201519450.230 Why?
Survival Rate52019128230.220 Why?
Postpartum Hemorrhage120082750.220 Why?
Cohort Studies142024417180.220 Why?
Carcinoma, Lobular220194800.220 Why?
Drug Administration Schedule4201948550.220 Why?
Cyclophosphamide4202222270.220 Why?
Ketones220211830.210 Why?
Neoadjuvant Therapy3201929020.210 Why?
Furans220211990.210 Why?
Medicare11202468130.210 Why?
Follow-Up Studies92020393170.210 Why?
Peripheral Nervous System Diseases220197160.210 Why?
Lymph Node Excision5202412670.200 Why?
Acupuncture, Ear12022130.200 Why?
Practice Guidelines as Topic5202474350.200 Why?
Sentinel Lymph Node Biopsy420227340.190 Why?
Palliative Care1201736410.190 Why?
California2201514390.180 Why?
Leukemia, Myeloid, Acute1201636260.180 Why?
Piperazines2202425480.180 Why?
Odds Ratio5201796600.180 Why?
Young Adult172024599800.170 Why?
Patient Care320226280.170 Why?
Medical Records2201814090.170 Why?
Retrospective Studies212024816590.160 Why?
Xanthones12019230.160 Why?
Pyridines2202428900.160 Why?
Age Distribution3202428700.160 Why?
Pilot Projects3202287320.160 Why?
Interinstitutional Relations120202350.160 Why?
Treatment Outcome132024652950.150 Why?
Perforin120181670.150 Why?
Obesity22018130850.150 Why?
Premenopause2201310390.150 Why?
Radiotherapy3202415000.140 Why?
Quality of Life72024134850.140 Why?
Receptors, Steroid120171570.140 Why?
Logistic Models42017132840.130 Why?
Medication Systems, Hospital120171540.130 Why?
Nitriles220219800.130 Why?
Epidemiologic Factors12015360.130 Why?
Cognition1201370590.120 Why?
Feasibility Studies3202253110.120 Why?
Interferons120197160.120 Why?
Tissue Distribution1201922750.120 Why?
Eukaryotic Initiation Factor-312015470.120 Why?
Acupuncture Therapy120194850.120 Why?
Proportional Hazards Models62023125360.120 Why?
Early Detection of Cancer3202232360.120 Why?
Craniotomy120197360.120 Why?
Clinical Trials, Phase III as Topic120198780.120 Why?
Lung Neoplasms52024134910.120 Why?
Lymphohistiocytosis, Hemophagocytic120182720.120 Why?
Risk Assessment82024242990.120 Why?
Anthracyclines120162860.120 Why?
Randomized Controlled Trials as Topic32020103930.110 Why?
Incidence62024215260.110 Why?
Minority Health12015790.110 Why?
Risk Factors112024748860.110 Why?
Gene Expression Profiling3202095320.110 Why?
Patient Education as Topic2202123370.110 Why?
Adverse Drug Reaction Reporting Systems120174970.110 Why?
Aftercare120209150.110 Why?
Patients120209080.110 Why?
Eligibility Determination120164210.100 Why?
Fatigue2201815560.100 Why?
Factor Analysis, Statistical1201510020.100 Why?
Neoplasm Invasiveness3201936110.100 Why?
Hormones220218650.100 Why?
Molecular Targeted Therapy1202428240.100 Why?
Decision Support Techniques2202120060.100 Why?
Demography1201716410.100 Why?
Lymphatic Metastasis2201729000.100 Why?
Consensus2202132070.100 Why?
Attitude to Health1202120230.100 Why?
Time Factors72024401540.100 Why?
Physical Fitness120167440.100 Why?
Menopause1202016550.100 Why?
Glioblastoma1200734610.100 Why?
Triazoles120179030.100 Why?
Anticoagulants1200848540.100 Why?
Insurance, Health, Reimbursement120153880.100 Why?
Self Report3201837730.090 Why?
Prospective Studies92024548860.090 Why?
Confidence Intervals2201829200.090 Why?
Administration, Oral1201940260.090 Why?
Dose-Response Relationship, Drug22013107480.090 Why?
Evidence-Based Practice120154990.090 Why?
Multivariate Analysis22015120690.090 Why?
Minority Groups2201612140.090 Why?
Deglutition Disorders120176400.090 Why?
Interferon-gamma1201931540.090 Why?
Health Insurance Portability and Accountability Act120111050.090 Why?
Connecticut120113650.090 Why?
Women's Health1202020820.090 Why?
Resilience, Psychological120188070.090 Why?
Pyrazoles1202120280.090 Why?
Estradiol1201719510.090 Why?
Comorbidity22015105820.090 Why?
Radiation Injuries1201711960.080 Why?
Long-Term Care120136310.080 Why?
Chi-Square Distribution1201534310.080 Why?
Leukemia1201715180.080 Why?
Risk2202096060.080 Why?
Deoxycytidine120138860.080 Why?
Adolescent72021890460.070 Why?
Fluorouracil1201316520.070 Why?
Health Care Surveys1201524280.070 Why?
Guideline Adherence1201822320.070 Why?
Social Class2202120070.070 Why?
Male1520243642030.070 Why?
Survival Analysis32016100920.070 Why?
Decision Making2202139510.070 Why?
Quinazolines1201313690.070 Why?
Medicaid3202028360.070 Why?
Longitudinal Studies32019147660.070 Why?
Infusions, Intravenous1201122270.070 Why?
Databases, Factual3201780680.060 Why?
Anxiety1202146700.060 Why?
Data Collection1201533210.060 Why?
Genomics1202159240.060 Why?
Angiogenesis Inhibitors1201520550.060 Why?
Quality Indicators, Health Care1201518040.060 Why?
Pain1202051010.060 Why?
Radiology1201821060.060 Why?
Educational Status1201225110.060 Why?
Workflow220228590.060 Why?
American Cancer Society12024690.060 Why?
Blood-Brain Barrier1201110290.060 Why?
Internet1201631140.060 Why?
Patient Satisfaction1201634880.050 Why?
Exercise2201959540.050 Why?
Depression2202182340.050 Why?
Diagnostic Imaging1201735300.050 Why?
Insurance Claim Review220177440.050 Why?
Guidelines as Topic2202013960.050 Why?
Polymorphism, Single Nucleotide22020160360.050 Why?
Mitosis1200711760.050 Why?
Prevalence22017158510.050 Why?
Hospitalization22023108150.050 Why?
Case-Control Studies32024222540.050 Why?
National Cancer Institute (U.S.)120223000.050 Why?
Pandemics1202187360.050 Why?
Neoplasms, Radiation-Induced120245420.040 Why?
Aging2201987290.040 Why?
Doxorubicin2201722290.040 Why?
Antidepressive Agents1201229120.040 Why?
Family1201132100.040 Why?
Neuropsychological Tests1201371210.040 Why?
Small Cell Lung Carcinoma120244540.040 Why?
Evidence-Based Medicine1201137000.040 Why?
Clinical Competence1201548590.040 Why?
Nausea120226820.040 Why?
Academic Medical Centers2202027830.040 Why?
Cesarean Section1200814190.040 Why?
Disease Management2202025310.040 Why?
Genes, erbB-2120191620.040 Why?
Vomiting120226550.040 Why?
Frail Elderly120237810.040 Why?
Heartburn12017710.030 Why?
Propensity Score2201619710.030 Why?
Brain22020271630.030 Why?
Cancer Care Facilities120184270.030 Why?
Research Design2202262100.030 Why?
Mediastinum120172720.030 Why?
Drug Prescriptions2201716640.030 Why?
Contract Services12015900.030 Why?
Multicenter Studies as Topic1202017330.030 Why?
Medically Uninsured120208380.030 Why?
Drug Therapy120175040.030 Why?
Amino Acid Substitution1201817430.030 Why?
Hematopoiesis1202320560.030 Why?
Taxoids120176650.030 Why?
Antigen Presentation1201912500.030 Why?
Office Visits120175950.030 Why?
Cell Line, Tumor22020170970.030 Why?
Observer Variation1201826160.030 Why?
Morbidity1201817540.030 Why?
Continuity of Patient Care1201910780.020 Why?
Exercise Therapy120199390.020 Why?
Disease Susceptibility1201817910.020 Why?
Mutation32023302110.020 Why?
Proton Pump Inhibitors120175510.020 Why?
Linear Models1202158750.020 Why?
Colorectal Neoplasms1201169660.020 Why?
Magnetic Resonance Imaging32020365820.020 Why?
Xenograft Model Antitumor Assays1201936080.020 Why?
Reproducibility of Results22021201690.020 Why?
Drug Labeling120122510.020 Why?
Preoperative Care1201922520.020 Why?
Vascular Endothelial Growth Factor A1202035110.020 Why?
Tumor Burden1201519030.020 Why?
Poverty1202127190.020 Why?
Aromatase Inhibitors120125190.020 Why?
Pyrimidines1202130440.020 Why?
Health Personnel1202233870.020 Why?
Prostatic Neoplasms12011110970.020 Why?
Drug Approval120158200.020 Why?
Drug Interactions1201214190.020 Why?
Qualitative Research1201931390.020 Why?
Child, Preschool22021426060.020 Why?
Lymphoma1201718960.020 Why?
Alleles1201868930.020 Why?
Body Composition1201624540.020 Why?
Boston1202093600.020 Why?
Tumor Microenvironment1201939440.020 Why?
Pregnancy12008302380.020 Why?
Immunosuppressive Agents1201842100.020 Why?
United States Food and Drug Administration1201216720.010 Why?
Cell Proliferation12019104550.010 Why?
Cross-Sectional Studies12024263250.010 Why?
Gene Expression Regulation, Neoplastic1201786280.010 Why?
Positron-Emission Tomography1201765500.010 Why?
Predictive Value of Tests12016154240.010 Why?
Infant12019364850.010 Why?
Signal Transduction12019236210.010 Why?
Tomography, X-Ray Computed12018207410.010 Why?
Mice12019819120.010 Why?
Child12019807710.010 Why?
Animals120191689650.000 Why?
Freedman's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (304)
Explore
_
Co-Authors (103)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Physical Neighbors
_
© 2025 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.